期刊
INTERNATIONAL JOURNAL OF ONCOLOGY
卷 51, 期 6, 页码 1842-1850出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2017.4155
关键词
Ewing's sarcoma; microRNA; miR-20b; transforming growth factor-beta receptor II; MYC
类别
资金
- National Cancer Center Research and Development [26-A-4]
- Japan Society for the Promotion of Science [15K10451, 16K10866, 16K20063]
- Grants-in-Aid for Scientific Research [16K10866, 15K10451, 16K20063] Funding Source: KAKEN
Transforming growth factor-beta receptor II (TGFBR2) is implicated in various types of cancer. Most molecules involved in the TGF-beta pathway can be degraded by one or more microRNAs (miRNAs). In the present study, we show that miRNA plays an important role in down-regulating TGFBR2 expression in Ewing's sarcoma (ES) cells. Microarray-based analyses revealed that the expression of miR-20b was significantly increased, whereas TGFBR2 and MYC were significantly downregulated and upregulated, respectively, in all ES cells compared to their expression in human mesenchymal stem cells (hMSCs). In ES cell lines, anti-miR-20b increased TGFBR2 expression and significantly decreased MYC expression, showing an inverse relationship with TGFBR2. The induction by anti-miR-20b further prohibited ES cell growth and cell cycle progression. Moreover, decreased miR-20b in ES cells significantly inhibited tumor growth in vivo. Taken together, these results suggest that miR-20b behaves as an oncogene in ES when its overexpression is unregulated by targeting TGFBR2. Because downstream TGFBR2 and TGF-beta signaling regulate cell cycle, apoptosis, and tumor proliferation via MYC, our findings may contribute to new targeted therapies for ES.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据